Personal tools

MCL coexpression mm9:421: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0.619408584063706,0.194002013165964,0.271063807885415,0.127893569522672,0.0787347879396902,0.342107724764957,0.262444414487012,0,0,0,0.0636076933539527,0.105247439647798,0,0,0.129239737494397,0.100783889465809,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.318218134456778,0,0.17187568289743,0,0,0,0,0,0,0,0,0,0.302481506279645,0.118440132246796,0.174560973302262,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.110544086345426,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.482424358947677,0.689324600957046,0.471799821504829,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4922908685298,0.597411001582423,0.380949209025899,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.480103482368008,0.537622738924076,0.457104378282297,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.017645963428501,0,0,0,0,0,0.016775467615084,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0.619408584063706,0.194002013165964,0.271063807885415,0.127893569522672,0.0787347879396902,0.342107724764957,0.262444414487012,0,0,0,0.0636076933539527,0.105247439647798,0,0,0.129239737494397,0.100783889465809,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.318218134456778,0,0.17187568289743,0,0,0,0,0,0,0,0,0,0.302481506279645,0.118440132246796,0.174560973302262,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.110544086345426,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.482424358947677,0.689324600957046,0.471799821504829,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4922908685298,0.597411001582423,0.380949209025899,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.480103482368008,0.537622738924076,0.457104378282297,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.017645963428501,0,0,0,0,0,0.016775467615084,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|gostat_on_MCL_coexpression=
|gostat_on_MCL_coexpression=
|ontology_enrichment_celltype=CL:0000988!5.93e-37!32;CL:0002032!5.93e-37!32;CL:0000037!5.93e-37!32;CL:0000566!5.93e-37!32;CL:0000837!5.93e-37!32;CL:0000838!5.44e-36!12;CL:0000542!4.75e-33!13;CL:0000051!4.75e-33!13;CL:0000084!5.75e-33!11;CL:0000827!5.75e-33!11;CL:0000791!1.70e-27!9;CL:0000789!1.70e-27!9;CL:0002420!1.70e-27!9;CL:0002419!1.70e-27!9;CL:0000790!1.70e-27!9;CL:0002320!3.60e-27!46;CL:0000134!3.60e-27!46;CL:0002242!1.98e-26!16;CL:0000738!9.66e-25!17;CL:0002087!9.66e-25!17;CL:0000624!1.23e-24!8;CL:0000219!1.55e-22!54;CL:0002031!5.90e-22!25;CL:0000893!1.32e-18!6;CL:0002489!1.32e-18!6;CL:0000898!1.32e-18!6;CL:0000809!1.32e-18!6;CL:0000810!1.32e-18!6;CL:0000895!1.32e-18!6;CL:0000808!1.32e-18!6;CL:0000894!1.32e-18!6;CL:0000806!1.32e-18!6;CL:0000807!1.32e-18!6;CL:0000805!1.32e-18!6;CL:0002425!1.32e-18!6;CL:0002436!1.32e-18!6;CL:0002427!1.32e-18!6;CL:0002428!1.32e-18!6;CL:0002429!1.32e-18!6;CL:0002433!1.32e-18!6;CL:0002431!1.32e-18!6;CL:0002432!1.32e-18!6;CL:0000034!4.21e-15!97;CL:0000723!1.13e-11!91;CL:0000048!1.13e-11!91;CL:0000049!3.21e-10!19;CL:0000548!2.33e-08!115;CL:0000255!2.33e-08!115;CL:0002371!4.86e-08!118
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002384!3.60e-27!46;UBERON:0002390!2.27e-09!45;UBERON:0003061!2.27e-09!45;UBERON:0002193!1.25e-08!48;UBERON:0002405!1.25e-08!48;UBERON:0002370!1.77e-07!23;UBERON:0000974!1.77e-07!23;UBERON:0004807!1.77e-07!23;UBERON:0005058!1.77e-07!23;UBERON:0003351!1.77e-07!23;UBERON:0009113!1.77e-07!23;UBERON:0003295!1.77e-07!23;UBERON:0009722!1.77e-07!23;UBERON:0005562!1.77e-07!23;UBERON:0007690!1.77e-07!23;UBERON:0006562!4.04e-07!24;UBERON:0003408!4.04e-07!24;UBERON:0001557!4.04e-07!24;UBERON:0001042!4.04e-07!24;UBERON:0008814!4.04e-07!24;UBERON:0009145!4.04e-07!24
}}
}}

Revision as of 20:40, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:80158316..80158334,+p@chr10:80158316..80158334
+
Mm9::chr11:21138176..21138179,-p@chr11:21138176..21138179
-
Mm9::chr15:80542424..80542435,-p@chr15:80542424..80542435
-
Mm9::chr16:75907266..75907275,+p@chr16:75907266..75907275
+
Mm9::chr16:84583763..84583779,-p@chr16:84583763..84583779
-
Mm9::chr16:92824084..92824098,+p@chr16:92824084..92824098
+
Mm9::chr17:29530613..29530620,-p@chr17:29530613..29530620
-
Mm9::chr17:29530790..29530796,+p@chr17:29530790..29530796
+
Mm9::chr17:29530804..29530833,+p@chr17:29530804..29530833
+
Mm9::chr18:66630496..66630501,+p@chr18:66630496..66630501
+
Mm9::chr19:12869451..12869490,+p@chr19:12869451..12869490
+
Mm9::chr1:132918226..132918229,-p@chr1:132918226..132918229
-
Mm9::chr1:97564410..97564422,+p@chr1:97564410..97564422
+
Mm9::chr5:22892703..22892742,-p@chr5:22892703..22892742
-
Mm9::chr6:31076337..31076341,-p@chr6:31076337..31076341
-
Mm9::chr6:83267246..83267258,+p@chr6:83267246..83267258
+
Mm9::chr8:96889748..96889760,+p@chr8:96889748..96889760
+
Mm9::chr8:96889794..96889800,+p@chr8:96889794..96889800
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Cell Type
Ontology termp-valuen
hematopoietic cell5.93e-3732
hematopoietic oligopotent progenitor cell5.93e-3732
hematopoietic stem cell5.93e-3732
angioblastic mesenchymal cell5.93e-3732
hematopoietic multipotent progenitor cell5.93e-3732
lymphoid lineage restricted progenitor cell5.44e-3612
lymphocyte4.75e-3313
common lymphoid progenitor4.75e-3313
T cell5.75e-3311
pro-T cell5.75e-3311
mature alpha-beta T cell1.70e-279
alpha-beta T cell1.70e-279
immature T cell1.70e-279
mature T cell1.70e-279
immature alpha-beta T cell1.70e-279
connective tissue cell3.60e-2746
mesenchymal cell3.60e-2746
nucleate cell1.98e-2616
leukocyte9.66e-2517
nongranular leukocyte9.66e-2517
CD4-positive, alpha-beta T cell1.23e-248
motile cell1.55e-2254
hematopoietic lineage restricted progenitor cell5.90e-2225
thymocyte1.32e-186
double negative thymocyte1.32e-186
naive T cell1.32e-186
double-positive, alpha-beta thymocyte1.32e-186
CD4-positive, alpha-beta thymocyte1.32e-186
naive thymus-derived CD4-positive, alpha-beta T cell1.32e-186
DN4 thymocyte1.32e-186
DN1 thymic pro-T cell1.32e-186
DN2 thymocyte1.32e-186
DN3 thymocyte1.32e-186
immature single positive thymocyte1.32e-186
early T lineage precursor1.32e-186
mature CD4 single-positive thymocyte1.32e-186
resting double-positive thymocyte1.32e-186
double-positive blast1.32e-186
CD69-positive double-positive thymocyte1.32e-186
CD69-positive, CD4-positive single-positive thymocyte1.32e-186
CD4-positive, CD8-intermediate double-positive thymocyte1.32e-186
CD24-positive, CD4 single-positive thymocyte1.32e-186
stem cell4.21e-1597
somatic stem cell1.13e-1191
multi fate stem cell1.13e-1191
common myeloid progenitor3.21e-1019
animal cell2.33e-08115
eukaryotic cell2.33e-08115
somatic cell4.86e-08118


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:421&oldid=2156193"